PulseAugur
EN
LIVE 09:32:59

Expanded dataset boosts anti-cancer drug response prediction models

Researchers have developed a significantly expanded dataset for anti-cancer drug response prediction models, integrating millions of measurements and over 50,000 compounds. This new resource, built upon the IMPROVE benchmark, aims to improve model generalizability by increasing coverage of cancer types and chemical diversity. Initial testing showed that models trained on the expanded dataset demonstrated enhanced performance in predicting responses to previously unseen compounds, positioning it as a valuable community resource for developing novel anticancer drugs. AI

IMPACT Enhances the foundation for developing AI models aimed at discovering novel anticancer drugs.

RANK_REASON The item is an academic paper detailing a new dataset and its evaluation. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.LG →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Expanded dataset boosts anti-cancer drug response prediction models

COVERAGE [1]

  1. arXiv cs.LG TIER_1 English(EN) · Vincent Lavelle, Yitan Zhu, Kaitlyn Marlor, Thomas Brettin, Rick Stevens ·

    Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling

    arXiv:2608.11444v1 Announce Type: cross Abstract: Drug response prediction (DRP) models are an active area of research in pharmacogenomics, with growing potential to accelerate the identification of effective anticancer drugs. However, their predictive performance is often constr…